Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Sarcoma 1Plasma cell 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Multiple Myeloma 22Neoplasms, Plasma Cell 14Lymphoma, Non-Hodgkin 7Leukemia, Lymphocytic, Chronic, B-Cell 7Hodgkin Disease 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Mantle-Cell 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Leukemia, Myeloid, Acute 5Leukemia 5Burkitt Lymphoma 5Congenital Abnormalities 4Waldenstrom Macroglobulinemia 3Recurrence 3Myelodysplastic Syndromes 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3Leukemia, Myeloid, Accelerated Phase 3Dendritic Cell Sarcoma, Interdigitating 3Testicular Neoplasms 2Primary Myelofibrosis 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Plasma Cell 2Leukemia, Neutrophilic, Chronic 2

Interventions

Peripheral Blood Stem Cell Transplantation 21Mycophenolic Acid 16Cyclophosphamide 14fludarabine phosphate 13Tacrolimus 13Cyclosporine 13Whole-Body Irradiation 12Therapeutics 8Flow Cytometry 8Filgrastim 8Radiotherapy 7Psychiatric Rehabilitation 7Methylprednisolone 7Methotrexate 7Busulfan 7Antilymphocyte Serum 7Polymerase Chain Reaction 6Rituximab 4Ondansetron 4Etoposide 4Cord Blood Stem Cell Transplantation 4Transplantation 3Sirolimus 3Melphalan 3Interferon-alpha 3Granulocyte Colony-Stimulating Factor 3Early Intervention, Educational 3Bortezomib 3Aprepitant 3Amplified Fragment Length Polymorphism Analysis 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Hairy Cell × Carmustine × Plasma cell × Clear all
NCT00281879 2017-09-27

Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

OHSU Knight Cancer Institute

Phase 2 Terminated
200 enrolled 11 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡